| dc.contributor.author | Depledge, J | |
| dc.date.accessioned | 2012-07-18T11:34:48Z | |
| dc.date.available | 2012-07-18T11:34:48Z | |
| dc.date.issued | 2012-07-18 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/769 | |
| dc.description.abstract | European Conference in EGFR Inhibitors in Metastatic Breast Cancer, Glaxo Smith Kline, London. 16-17th October 2008, (invited speaker) | en_US |
| dc.subject | breast cancer | en_US |
| dc.subject | cancer | en_US |
| dc.subject | Treatment | en_US |
| dc.subject | EGFT | en_US |
| dc.title | EGFT inhibitors in metastatic breast cancer: quality and service improvements | en_US |
| dc.type | Other | en_US |